Marc Sanson

29.8k total citations · 6 hit papers
319 papers, 14.1k citations indexed

About

Marc Sanson is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Marc Sanson has authored 319 papers receiving a total of 14.1k indexed citations (citations by other indexed papers that have themselves been cited), including 224 papers in Genetics, 115 papers in Molecular Biology and 87 papers in Cancer Research. Recurrent topics in Marc Sanson's work include Glioma Diagnosis and Treatment (224 papers), Meningioma and schwannoma management (55 papers) and Brain Metastases and Treatment (50 papers). Marc Sanson is often cited by papers focused on Glioma Diagnosis and Treatment (224 papers), Meningioma and schwannoma management (55 papers) and Brain Metastases and Treatment (50 papers). Marc Sanson collaborates with scholars based in France, United States and Italy. Marc Sanson's co-authors include Khê Hoang‐Xuan, Ahmed Idbaïh, Karima Mokhtari, Jean‐Yves Delattre, Yannick Marie, Blandine Boisselier, Florence Laigle–Donadey, Alain Carpentier, Martin J. van den Bent and François Ducray and has published in prestigious journals such as The Lancet, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Marc Sanson

306 papers receiving 13.9k citations

Hit Papers

Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Impor... 2006 2026 2012 2019 2009 2016 2006 2014 2017 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
    2009 773 citations Marc Sanson, Yannick Marie et al. Journal of Clinical Oncology profile →
  2. Clinical trial of blood-brain barrier disruption by pulsed ultrasound
    2016 574 citations Marc Sanson, Khê Hoang‐Xuan et al. profile →
  3. Adjuvant Procarbazine, Lomustine, and Vincristine Improves Progression-Free Survival but Not Overall Survival in Newly Diagnosed Anaplastic Oligodendrogliomas and Oligoastrocytomas: A Randomized European Organisation for Research and Treatment of Cancer Phase III Trial
    2006 523 citations Martin J. van den Bent, Alain Carpentier et al. Journal of Clinical Oncology profile →
  4. MGMT testing—the challenges for biomarker-based glioma treatment
    2014 393 citations Michael Weller, Martin J. van den Bent et al. profile →
  5. Glioblastoma targeted therapy: updated approaches from recent biological insights
    2017 322 citations Mehdi Touat, Ahmed Idbaïh et al. profile →
  6. Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study
    2021 171 citations Funda Meric‐Bernstam, Rastislav Bahleda et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Sanson France 61 8.6k 5.2k 3.8k 3.1k 2.5k 319 14.1k
Johannes A. Hainfellner Austria 51 7.5k 0.9× 6.0k 1.2× 3.1k 0.8× 3.1k 1.0× 2.0k 0.8× 297 14.9k
Yingli Wolinsky United States 11 9.0k 1.0× 4.8k 0.9× 3.0k 0.8× 3.0k 1.0× 2.9k 1.2× 12 15.7k
Jean‐Yves Delattre France 62 7.9k 0.9× 3.7k 0.7× 2.5k 0.7× 4.0k 1.3× 3.2k 1.3× 216 14.4k
Johan M. Kros Netherlands 66 11.6k 1.3× 6.9k 1.3× 4.7k 1.2× 4.6k 1.5× 2.9k 1.2× 274 19.2k
Khê Hoang‐Xuan France 60 11.2k 1.3× 4.5k 0.9× 3.2k 0.9× 4.0k 1.3× 4.6k 1.9× 331 17.3k
Olivier Chinot France 52 7.5k 0.9× 3.1k 0.6× 2.4k 0.6× 3.3k 1.1× 1.9k 0.8× 296 11.7k
Dominique Figarella‐Branger France 61 10.1k 1.2× 6.1k 1.2× 2.9k 0.8× 3.3k 1.1× 3.8k 1.5× 421 19.3k
Christian Hartmann Germany 57 8.6k 1.0× 5.4k 1.1× 3.9k 1.0× 2.5k 0.8× 2.3k 0.9× 306 14.7k
Torsten Pietsch Germany 68 9.9k 1.2× 9.7k 1.9× 3.4k 0.9× 3.2k 1.1× 3.2k 1.3× 399 19.3k
David Capper Germany 58 7.8k 0.9× 5.2k 1.0× 3.4k 0.9× 2.5k 0.8× 2.1k 0.8× 230 13.4k

Countries citing papers authored by Marc Sanson

Since Specialization
Citations

This map shows the geographic impact of Marc Sanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Sanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Sanson more than expected).

Fields of papers citing papers by Marc Sanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Sanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Sanson. The network helps show where Marc Sanson may publish in the future.

Co-authorship network of co-authors of Marc Sanson

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Sanson. A scholar is included among the top collaborators of Marc Sanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Sanson. Marc Sanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Touat, Mehdi, Patrick R. Benusiglio, Philipp Euskirchen, et al.. (2025). A Specific Methylation Class Identifies BAP1‐Deficient Meningiomas, Including Meningeal Tumours With Poorly Differentiated Nonrhabdoid Histology. Neuropathology and Applied Neurobiology. 51(5). e70042–e70042. 1 indexed citations
2.
Capper, David, Guido Reifenberger, Pim J. French, et al.. (2023). EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection. Neuro-Oncology. 25(5). 813–826. 54 indexed citations
3.
Meric‐Bernstam, Funda, Rastislav Bahleda, Cinta Hierro, et al.. (2021). Futibatinib, an Irreversible FGFR1–4 Inhibitor, in Patients with Advanced Solid Tumors Harboring FGF / FGFR Aberrations: A Phase I Dose-Expansion Study. Cancer Discovery. 12(2). 402–415. 171 indexed citations breakdown →
4.
Cornish, Alex J., Ben Kinnersley, Philip Law, et al.. (2020). Searching for causal relationships of glioma: a phenome-wide Mendelian randomisation study. British Journal of Cancer. 124(2). 447–454. 9 indexed citations
5.
Peyre, Matthieu, et al.. (2020). Current Management of Large Vestibular Schwannomas for NF2 Patients in a National Reference Center. The Laryngoscope. 131(1). E98–E107. 4 indexed citations
6.
Bonnet, Charlotte, Laure Thomas, Dimitri Psimaras, et al.. (2016). Characteristics of gliomas in patients with somatic IDH mosaicism. Acta Neuropathologica Communications. 4(1). 31–31. 26 indexed citations
7.
Verreault, Maïté, Charlotte Schmitt, Lauriane Goldwirt, et al.. (2015). Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2 -Amplified and TP53 Wild-type Glioblastomas. Clinical Cancer Research. 22(5). 1185–1196. 81 indexed citations
8.
Bielle, Franck, Chiara Villa, Marine Giry, et al.. (2015). Chordoid Gliomas of the Third Ventricle Share TTF-1 Expression With Organum Vasculosum of the Lamina Terminalis. The American Journal of Surgical Pathology. 39(7). 948–956. 41 indexed citations
9.
Labussière, Marianne, Blandine Boisselier, Karima Mokhtari, et al.. (2014). Combined analysis of TERT , EGFR , and IDH status defines distinct prognostic glioblastoma classes. Neurology. 83(13). 1200–1206. 178 indexed citations
10.
Bent, Martin J. van den, Christian Hartmann, Matthias Preusser, et al.. (2013). Interlaboratory comparison of IDH mutation detection. Journal of Neuro-Oncology. 112(2). 173–178. 57 indexed citations
11.
12.
Boisselier, Blandine, Jaime Gállego Pérez‐Larraya, Marta Rossetto, et al.. (2012). Detection of IDH1 mutation in the plasma of patients with glioma. Neurology. 79(16). 1693–1698. 92 indexed citations
13.
Wang, Xiaowei, Blandine Boisselier, Marta Rossetto, et al.. (2012). Prognostic impact of the isocitrate dehydrogenase 1 single‐nucleotide polymorphism rs11554137 in malignant gliomas. Cancer. 119(4). 806–813. 24 indexed citations
14.
Bent, Martin J. van den, Lonneke A.M. Gravendeel, Thierry Gorlia, et al.. (2011). A Hypermethylated Phenotype Is a Better Predictor of Survival than MGMT Methylation in Anaplastic Oligodendroglial Brain Tumors: A Report from EORTC Study 26951. Clinical Cancer Research. 17(22). 7148–7155. 83 indexed citations
15.
Carpentier, Alain, Philippe Métellus, Rénata Ursu, et al.. (2010). Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study. Neuro-Oncology. 12(4). 401–408. 163 indexed citations
16.
Houillier, Caroline, Gentian Kaloshi, Karima Mokhtari, et al.. (2010). IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology. 75(17). 1560–1566. 402 indexed citations
17.
Bent, Martin J. van den, Hendrikus J. Dubbink, Yannick Marie, et al.. (2010). IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Clinical Cancer Research. 16(5). 1597–1604. 304 indexed citations
18.
Hallani, Soufiane El, Blandine Boisselier, Florent Péglion, et al.. (2010). A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain. 133(4). 973–982. 284 indexed citations
19.
Sanson, Marc, Yannick Marie, Sophie Paris, et al.. (2009). Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas. Journal of Clinical Oncology. 27(25). 4150–4154. 773 indexed citations breakdown →
20.
Hoang‐Xuan, Khê, Lucinda Aguirre‐Cruz, Karima Mokhtari, Y. Marie, & Marc Sanson. (2002). OLIG‐1 and 2 gene expression and oligodendroglial tumours. Neuropathology and Applied Neurobiology. 28(2). 89–94. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes A. Hainfellner Breakdown of academic impact, for papers by Yingli Wolinsky Breakdown of academic impact, for papers by Jean‐Yves Delattre Breakdown of academic impact, for papers by Johan M. Kros Breakdown of academic impact, for papers by Khê Hoang‐Xuan Breakdown of academic impact, for papers by Olivier Chinot Breakdown of academic impact, for papers by Dominique Figarella‐Branger Breakdown of academic impact, for papers by Christian Hartmann Breakdown of academic impact, for papers by Torsten Pietsch Breakdown of academic impact, for papers by David Capper
Rankless by CCL
2026